Inventia Life Science | The Culture Newsletter
From 3D Models to Real-World Impact | February 2026

Welcome to the February edition of The Culture.

Across oncology, infectious disease, and toxicology research, the conversation is shifting toward scalable, human-relevant systems that generate actionable biological insight. This month, we highlight expert discussion, new publications, recent coverage, and upcoming opportunities to engage with the Inventia Life Science team.

On-Demand Webinar: Rethinking the Role of Animals in Molecular Biology

Momentum around New Approach Methodologies (NAMs) continues to build as researchers and regulators reexamine where animal studies add value and where advanced in vitro systems can deliver stronger insight.

Inventia Life Science’s Co-Founder and COO, Cameron Ferris, PhD, joined leaders from academia and industry in this expert roundtable hosted by The Scientist.

The discussion explores scientific, ethical, and practical drivers behind the shift toward scalable 3D cell models and other human-relevant approaches.

Watch the conversation →

Inventia Insights: User Stories and Guides from the Blog

FDA and NIH Are Moving Beyond Animal Models
A closer look at regulatory signals and funding trends accelerating the transition toward advanced in vitro systems.
Read the story →

Building Patient-Specific Drug Screens in Weeks, Not Months
How scalable 3D workflows are enabling precision oncology strategies and reducing time to insight.
Discover how →

RASTRUM Cloud: Easily Design Advanced 3D Cell Models
Improving experimental design, documentation, and reproducibility across 3D cell culture workflows.
Explore the power of RASTRUM Cloud →

Publication Spotlight: High-throughput bioprinted 3D cultures for probing host–pathogen interactions in bioinspired microenvironments

A newly published study from the University of Delaware describes a high-throughput 96-well 3D macrophage–bacteria co-culture model generated using bioprinting.

Synthetic extracellular matrices were tuned to mimic healthy and fibrotic lung stiffness, revealing that microenvironment mechanics influence macrophage cytokine responses to Pseudomonas aeruginosa.

This work highlights the value of scalable, bioinspired 3D platforms for studying human host–pathogen interactions in physiologically relevant environments.

Read the publication →

In the News: Printing Mini Livers to Save Lives

Recent coverage features researchers at Defence Science and Technology Group using RASTRUM Allegro to generate miniature liver organoids for evaluating drug toxicity and repurposing countermeasures.

By combining stem cell biology with drop-on-demand bioprinting, the program aims to improve predictive toxicology while reducing reliance on animal studies.

Read the story →

Upcoming Events:

HNS Models Symposium – Adelaide, South Australia

March 3–5 | SAHMRI Auditorium

We are proud to sponsor and exhibit at the 2026 HNS Models Symposium, where our team will also host a hands-on workshop on March 5 from 10am–5pm demonstrating scalable neuronal 3D model generation using RASTRUM.

Register for the event →

3D Cell Culture Workshop | University of Sydney

March 12 | Molecular Bioscience Building | Centre for Drug Discovery Innovation

Join Inventia Life Science's Joe Gillson PhD as he shares automated, scalable 3D workflows for drug discovery, precision medicine, and developmental biology.

Register for the workshop →